Alerce Investment Management, L.p.

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 5Value: $56.8MLatest: 2024Q4

Alerce Investment Management, L.P. is an institutional investment manager that filed its latest Form 13F for 2024Q4, reporting 5 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "ANNX",
  "AKBA",
  "AMWL",
  "WHWK",
  "VRNA"
]

Filing Details

13F-HR • 2024-12-31

SEC FilingSEC DataHachi Filing

Report Date: 2024-12-31
Filing Date: 2025-02-14
Total Holdings: 5
Total Value: 56800164
Accession Number: 0000895345-25-000069
Form Type: 13F-HR
CIK: alerce-investment-management-lp
Manager Name: Alerce-Investment-Management-Lp

Data Enrichment

100% identified

5 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

5 positions • $56.8M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Annexon, Inc.

ANNX|03589W102

Shares:7.4M

Value:$38.0M

% of Portfolio:66.9% ($38.0M/$56.8M)

Akebia Therapeutics, Inc.

AKBA|00972D105

Shares:5.7M

Value:$10.9M

% of Portfolio:19.2% ($10.9M/$56.8M)

Verona Pharma plc

VRNA|925050106

Shares:88.0K

Value:$4.1M

% of Portfolio:7.2% ($4.1M/$56.8M)

American Well Corp

AMWL|03044L204

Shares:523.8K

Value:$3.8M

% of Portfolio:6.7% ($3.8M/$56.8M)

Whitehawk Therapeutics, Inc.

WHWK|00032Q104

Shares:659

Value:$2.1K

% of Portfolio:0.0% ($2.1K/$56.8M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Annexon, Inc.(ANNXcusip03589W102)	7.4M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$38.0M	66.9% ($38.0M/$56.8M)	QoQ -13.34% (-$5.9M) YoY-
Akebia Therapeutics, Inc.(AKBAcusip00972D105)	5.7M	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$10.9M	19.2% ($10.9M/$56.8M)	QoQ +43.93% (+$3.3M) YoY-
Verona Pharma plc(VRNAcusip925050106)	88.0K	QoQ -57.25% (-117.9K) YoY-	All Managers (Combined)	$4.1M	7.2% ($4.1M/$56.8M)	QoQ -31.00% (-$1.8M) YoY-
American Well Corp(AMWLcusip03044L204)	523.8K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$3.8M	6.7% ($3.8M/$56.8M)	QoQ -23.52% (-$1.2M) YoY-
Whitehawk Therapeutics, Inc.(WHWKcusip00032Q104)	659	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$2.1K	0.0% ($2.1K/$56.8M)	QoQ +53.09% (+$721) YoY-